Company Profile
John Wiley & Sons, Inc., a publisher, provides authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning in the United States, the United Kingdom, Germany, and internationally. It operates through Research and Learning segment. The company's Research segment provides scientific, technical, medical, and scholarly journals, as well as related content and services in the areas of physical sciences and engineering, health sciences, social sciences, and humanities, and life sciences. This segment sells its products direct to research libraries and library consortia, as well as to researchers and professional society members, and other customers; and through independent subscription agents. The company's Learning segment offers scientific, professional, and education print and digital books; digital courseware to support students and instructors, and assessment services for businesses and professionals. This segment sells its products and services to business and leadership, technology, behavioral health, engineering/architecture, science, and professional education categories through brick-and-mortar and online retailers, wholesalers who supply such bookstores, college bookstores, individual practitioners, corporations, distributor networks, and government agencies. John Wiley & Sons, Inc. was founded in 1807 and is headquartered in Hoboken, New Jersey.
Latest News
John Wiley & Sons (WLY) Could Be a Great Choice
INFQ Stock Surges After Three DOE Awards In $5B Genesis Mission – HPE, WLY Also Gain On Joining Federal AI Initiative
Wiley Joins U.S. Department of Energy's Genesis Mission Consortium to Advance AI-Powered Scientific Discovery
SMR Stock Powers Ahead After Best Day In Over A Month: What’s Behind The Surge?
SLS Stock Tracks Worst Month Since March: Investor Slashes Stake By Over 30% As Quiet Period Begins Ahead Of AML Readout
| Sector | Communication Services |
| Industry | Publishing |
| Website | https://www.wiley.com |
| Audit Risk | 2 |
| Board Risk | 9 |
| Overall Risk | 9 |
| Market Cap | 2.52B |
| Trailing P/E | 11.91 |
| Forward P/E | 9.35 |
| Dividend Rate | 1.42 |
| Dividend Yield | 2.87% |
| Trailing Annual Div. Rate | 1.42 |
| Trailing Annual Div. Yield | 2.91% |
| Trailing EPS | 4.16 |
| Forward EPS | 5.3 |
| Book Value | 16.68 |
| Price-to-Book | 2.97 |
| Enterprise-to-Revenue | 1.91 |
| Enterprise-to-EBITDA | 9.12 |
| Short Ratio | 5.06 |
| Ex-Dividend Date | 07/07/2026 |
| Dividend Date | 07/23/2026 |
| Earnings Date | 09/03/2026 |
| Earnings Call Date | 06/16/2026 |
| Earnings Average | 0.4 |
| Earnings Low | 0.4 |
| Earnings High | 0.4 |
| Revenue Average | 380.20M |
| Revenue Low | 380.20M |
| Revenue High | 380.20M |